Much has changed in the last decade except overall survival: A Swiss single center analysis of treatment and survival in patients with stage IV non-small cell lung cancer

BACKGROUND: Molecular therapies for cancers with targetable driver mutations and immunotherapies have revolutionized treatment of non-small cell lung cancer (NSCLC) during the last decade. International treatment guidelines began integrating targeted therapies in 2009 and immunotherapies in 2015. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallrabenstein, Till, Del Rio, Jessica, Templeton, Arnoud J., Buess, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259780/
https://www.ncbi.nlm.nih.gov/pubmed/32470017
http://dx.doi.org/10.1371/journal.pone.0233768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259780/
https://www.ncbi.nlm.nih.gov/pubmed/32470017
http://dx.doi.org/10.1371/journal.pone.0233768

Ejemplares similares